Long COVID research

This study is taking place in Ethiopia and Uganda. It uses both qualitative and quantitative approaches and a case control study design to explore the relationship between past SARS-CoV-2 infection and malaria risk. A sample size of 2400 cases and 2400 controls (n=4800) will be enrolled from both countries. In Ethiopia, the researchers will conduct the study in three hospitals: one in Addis Ababa and two in Hawassa. In Uganda, the study will be conducted in different COVID-19 treatment centres across the country. The study population includes individuals across all age groups, both male and female, with previous SARS-CoV-2 infection (who were either hospitalised or not hospitalised during acute illness) as well as those without. Three overarching questions underpin this study: How do people with long term complications of COVID-19 (including those who were never hospitalised) experience the development, course and resolution of the illness over time? What services have they accessed (or tried to access), and what was their experience of those services? What are their ideas for improving the management of their condition and the design and delivery of services?

Project details

Epidemiology
Measurement of Transmission

Mar 2021 — Mar 2024

$854,999

Ethiopia
Uganda